The Clinical Research Ethics Board (CREB) reviews research that involves surgery, clinical interventions, exercise programs, and/or the analysis of clinical data.
New to UBC? See our video tutorials
Activities that fall under CREB review include: the administration or testing of drugs, medical devices, medical imaging or diagnostic techniques; and the taking of blood or other specimens. It also includes the analysis of laboratory, physiological, kinesiological or biological data obtained from physical interventions, medical records or clinical studies involving the linkage of data from existing databases.
The CREB reviews clinical research conducted at UBC's Vancouver campus and at Vancouver Coastal Health Authority sites (including UBC Hospital, Vancouver General Hospital, and GF Strong). It also reviews any clinical research that does not fall under the purview of site-specific REBs at BC Cancer, Children & Women’s Hospital or St. Paul's Hospital (Providence Health Care).
United States Federal Wide Assurance (FWA)
Under the United States Department of Health and Human Services (DHHS) Code of Federal Regulations 45: Part 46 A Protection of Human Subjects Section 46.103, every institution engaged in human subjects research supported or conducted by any United States Federal Department or Agency must have assurance of compliance approved by the United States Office for Human Research Protections (OHRP). The Assurance formalizes the institution’s commitment to protect human subjects.
OHRP has launched a webpage with information on the revised Common Rule’s clinical trial informed consent form posting requirement (45 CFR 46.116(h)). Please send questions or comments about the revised posting requirement to OHRP@hhs.gov.
OHRP Federalwide Assurance (FWA) and Institutional Review Board (IRB) assurance have been obtained for UBC and the CREB (REB is the Canadian terminology for an IRB). Click on the type of assurance below for more information:
Type of Assurance: Federal Wide (see details)
Policy Number: FWA00000668
Expiry Date: June 1, 2025
Type of Assurance: Institutional Review Board (see details)
Policy Number: IRB00001443
Expiry Date: January 17, 2022